Slide Decks on Anxiety Disorders
Anxiety disorders are among the most common types of mental disorder. Anxiety- or fear-related disorders include separation anxiety disorder, selective mutism, agoraphobia, social anxiety disorder, specific phobias, panic disorder, and generalized anxiety disorder. The 1-year prevalence of any anxiety disorder is 10-14%, and anxiety disorders often go untreated – with some research suggesting that less than one in four patients receive treatment.
In each slide deck, central topics and essential concepts related to anxiety disorders are introduced by leading experts in the field. All slide decks are completely free to download and use.
History, Definitions, and Diagnosis
This slide deck introduces the diagnosis of anxiety disorders, diagnostic instruments, and differential diagnosis to support diagnosis and clinical decision-making. Go to the slide deck.
Epidemiology and burden
Anxiety disorders are among the most common types of mental disorder; however, estimates of the prevalence of anxiety disorders vary. This slide deck introduces both the epidemiology and burden of anxiety disorders. Go to the slide deck.
Course, Natural History, and Prognosis
This slide deck introduces the course of anxiety disorders, central research in the field, and factors that predict progression and outcomes. Go to the slide deck.
Neurobiology and Aetiology
This slide deck introduces the neurobiology of fear and anxiety responses, early adversity and anxiety disorders, threat conditioning and fear learning, neuroimaging insights into anxiety disorders, genetics and anxiety disorders, and more. Go to the slide deck.
Treatment principles
This slide deck introduces both psychotherapy and pharmacotherapy for anxiety disorders, as well as treatment considerations, and principles of management of anxiety disorders. Go to the slide deck.
Comorbidities
This slide deck introduces psychiatric, neurological, and somatic comorbidities, as well as co-conditions of anxiety disorders. Epidemiological studies indicate a high rate of comorbidity in people with psychiatric disorders, ranging from 60–79%. Go to the slide deck.
Articles about Anxiety Disorders
The need for treatment of an anxiety disorder is determined by the severity and duration of anxiety symptoms, the degree of associated distress, the level of impact on everyday life, and the coexistence of depressive symptoms. The following articles highlight emerging topics of interest within research and clinical practice.
- Virtual Reality in Anxiety – An Overview
Virtual Reality (VR) technology enables a new form of exposure therapy through the creation of a so-called virtual world, known as “in-virtuo” exposure. - Emerging Pharmacological Treatments for Anxiety Disorders
This article examines the limitations of current treatments for anxiety disorders and surveys promising new pharmacological approaches such as novel GABAergic agents, psychedelics, and neuropeptide modulators.
Watch Videos about Anxiety Disorders
Access our video series explaining complex topics, illustrating key concepts, and discussing current issues with anxiety disorders. Learn about the key features of current psychotherapeutic and pharmacological treatments, epidemiology, comorbidity, and beyond.
Comorbidity in Anxiety Disorders
In this video, Professor Dr. Milan Latas explains that comorbidity in anxiety disorders is often under-recognized in routine clinical practice, which can obscure the true clinical picture.
Current Psychotherapeutic Treatments
In this video, Professor Dr. Stefan G. Hofmann discusses the effectiveness of exposure therapy and cognitive behavioral interventions in treating anxiety disorders.
Growing Burden from Anxiety Disorders
In the video, Professor Dr. Brenda Penninx highlights a significant increase in the prevalence of anxiety disorders, with a 50% rise over the last decade, affecting about 10% of the population.
Dual Treatment Approaches for Anxiety Disorders
In this video, Professor Dr. David Baldwin highlights the dual treatment approaches for anxiety disorders: pharmacological and psychotherapeutic treatments.
Course and Progression of Anxiety Disorders
In this video, Professor Dr. Dan Stein highlights the dynamic nature of anxiety disorders, emphasizing the need to re-conceptualize them from a course perspective.
Pharmacological Anxiety Treatments
In this video, Professor Nicolas Singewald discusses the emerging opportunities and challenges associated with pharmaceutical treatments for anxiety disorders.
Download Illustrations & Figures about Anxiety Disorders
The treatment of anxiety disorders involves acute treatment, which alleviates the immediate symptoms and is continued into maintenance treatment, which aims to prevent the recurrence of mood disturbances. Download and use our free images illustrating various aspects of anxiety disorders. These are some of the selected images – further images regarding anxiety disorders are accessible via the button below.
3D Brain Atlas
Several structural differences have been shown in neuroimaging studies of people with anxiety disorders. Reduced grey matter volume has been found within regions of the prefrontal cortex, the right insula, and other brain regions1. A different analysis of functional connectivity in people with GAD found that, compared with controls, people with anxiety had changes in key nodes of the resting state network, including reduced volumes in the hippocampus, anterior cingulate cortex, and amygdala2.
